Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aytu BioScience Inc

AYTU
Current price
1.50 USD -0.05 USD (-3.23%)
Last closed 1.69 USD
ISIN US0547548745
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 8 609 118 USD
Yield for 12 month -48.81 %
1Y
3Y
5Y
10Y
15Y
AYTU
21.11.2021 - 28.11.2021

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado. Address: Denver Corporate Center III, Denver, CO, United States, 80237

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.00 USD

P/E ratio

Dividend Yield

Current Year

+81 002 000 USD

Last Year

+107 399 000 USD

Current Quarter

+16 574 000 USD

Last Quarter

+17 976 000 USD

Current Year

+54 586 000 USD

Last Year

+66 632 000 USD

Current Quarter

+11 985 000 USD

Last Quarter

+11 906 000 USD

Key Figures AYTU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 6 113 000 USD
Operating Margin TTM -4.45 %
PE Ratio
Return On Assets TTM -1.06 %
PEG Ratio
Return On Equity TTM -47.24 %
Wall Street Target Price 8.00 USD
Revenue TTM 81 002 000 USD
Book Value 4.64 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -41.50 %
Dividend Yield
Gross Profit TTM 66 632 000 USD
Earnings per share -1.70 USD
Diluted Eps TTM -1.70 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -19.56 %

Dividend Analytics AYTU

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History AYTU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 06.01.2023
Dividend Date 09.12.2020

Stock Valuation AYTU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.33
Enterprise Value Revenue 0.063
Price Sales TTM 0.11
Enterprise Value EBITDA 0.70
Price Book MRQ 0.29

Financials AYTU

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AYTU

For 52 weeks

1.38 USD 3.45 USD
50 Day MA 1.87 USD
Shares Short Prior Month 120 797
200 Day MA 2.58 USD
Short Ratio 10.45
Shares Short 118 397
Short Percent 3.92 %